PCVX

Vaxcyte (PCVX)

About Vaxcyte (PCVX)

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.

Details

Daily high

$92.06

Daily low

$88.92

Price at open

$89.61

52 Week High

$121.06

52 Week Low

$58.10

Market cap

11.2B

Dividend yield

0.00%

Volume

698,019

Avg. volume

1.2M

P/E ratio

-19.16

Vaxcyte News